Principal Securities, Inc. Ishares Tr Genomics Immunology Transaction History

Principal Securities, Inc.

  • $5.32 Trillion
  • Q2 2025

A detailed history of Principal Securities, Inc. transactions in Ishares Tr Genomics Immunology stock. As of the latest transaction made, Principal Securities, Inc. holds 187 shares of IDNA stock, worth $4,491. This represents 0.0% of its overall portfolio holdings.

Number of Shares
187
Previous 1,319 85.82%
Holding current value
$4,491
Previous $29.8 Million 87.15%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
SELL
$17.92 - $21.5 $20,285 - $24,338
-1,132 Reduced 85.82%
187 $3.84 Million
Q4 2024

Jan 30, 2025
SELL
$22.38 - $25.53 $22,760 - $25,964
-1,017 Reduced 43.54%
1,319 $29.8 Million
Q3 2024

Oct 28, 2024
BUY
$22.86 - $25.49 $3,794 - $4,231
166 Added 7.65%
2,336 $57.5 Million
Q2 2024

Jul 31, 2024
BUY
$21.71 - $24.69 $130 - $148
6 Added 0.28%
2,170 $50.2 Million
Q1 2024

May 10, 2024
SELL
$22.28 - $25.2 $9,446 - $10,684
-424 Reduced 16.38%
2,164 $52.1 Million
Q4 2023

Feb 07, 2024
BUY
$17.37 - $23.3 $44,953 - $60,300
2,588 New
2,588 $59.6 Million

Others Institutions Holding IDNA

# of Institutions
57
Shares Held
2.19M
Call Options Held
0
Put Options Held
0
View Full List

About ISHARES TR GENOMICS IMMUNOLOGY

IDNA Quotes by TradingView
  • Ticker IDNA
  • Sector ETFs
  • Industry ETFs
More about IDNA
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email